Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Cancer Discov. 2011 Jun;1(1):12-3. doi: 10.1158/2159-8274.CD-11-0045. Epub 2011 Jun 1.
Wang and colleagues identify a fusion between UBE2L3 and KRAS in a subset of metastatic prostate cancers.
王及其同事在一部分转移性前列腺癌中鉴定出 UBE2L3 和 KRAS 之间的融合。